Drugs for No Sleep

The strangest line in my notes on Zero to One isn’t about startups.

It’s about drugs.

Invent something completely new → e.g., drugs for no sleep.

That’s it. No context. Just a pharmaceutical fever dream wedged between “Bad plan over no plan” and PayPal, like a raccoon that wandered into a board meeting and started taking minutes.

It’s Peter Thiel’s example. A pill that safely eliminates the need for sleep wouldn’t have competitors. It wouldn’t even have a category. Nobody would hold it up next to a mattress and compare prices.

That’s the whole book in one absurd product: build the thing nobody can copy.

Here’s the joke. The book is a copy.

Zero to One started as a Stanford course. A student named Blake Masters wrote down the lectures, the notes went viral, and the two of them turned them into the book. So what I have is notes on a book that was notes on a class.

A copy of a copy. Of an argument against copies.

*

Thiel’s case is simple and slightly rude: competition destroys profit.

Two cafés. Same street. Same oat milk, same Edison bulbs, same guy sighing into an acoustic guitar on the speakers. Nothing separates them, so they fight with the only weapon left. Price. Both survive. Neither gets rich. Both call it the market.

His alternative sounds like a crime. Monopoly. But he doesn’t mean a villain in a top hat. He means a company so good that nobody can offer a close substitute.

Not cheaper. Not slightly better. Ten times better. Or so new there’s nothing to compare it to.

Like a pill for no sleep.

*

Then comes the line marketers will hate.

Product before branding.

A few pages later, Thiel holds up the iPad as a tenfold leap. Through design. Not ads. Not a logo. Design built into the thing itself.

That’s the real distinction. Bad branding is lipstick on a commodity. Good branding answers a question the product has already earned the right to ask.

Why this one. And not the café next door.

If the only answer is a nicer cup, it isn’t a brand. It’s a price war with better fonts.

*

The irony gets better.

Economists at the Mises Institute pointed out that everything Thiel praises, from out-innovating rivals to outgrowing them, is still competing. He just refuses the field everyone else picked.

And the line everyone quotes? Not his headline. The Wall Street Journal took a chapter called “All Happy Companies Are Different” and renamed it “Competition Is for Losers.”

Even the case against competition had to elbow its way onto the newsstand.

*

One note on my list reads like the book confessing:

Every company starts only once. Statistics don’t work when the sample size is one.

Thiel admits as much in the preface. There can’t be a formula for this. Anything you can teach as a formula has already been done.

Which makes Zero to One a strange object. A #1 New York Times bestseller, read by a crowd of founders, all trying to learn how not to be a crowd.

Then again, a book can’t give you an idea. It can only make your current one look painfully ordinary.

So, back to the strangest line in my notes.

Drugs for no sleep.

The book never gives you the pill.

It keeps you up anyway.